Early and sustained increase in time in range 1 year after initiation of hybrid close loop therapy via telemedicine in type 1 diabetes patients.

Ana M GómezDiana Cristina Henao-CarrilloDarío ParraAlfonso KerguelenPablo JaramilloYaline GómezOscar Mauricio MuñozMartin Rondón

Published in: Acta diabetologica (2023)

HCL systems allow to improve TIR, TBR and glycemic variability safely, early and sustained up to 1 year of follow-up in patients with T1D and high risk of hypoglycemia followed through telemedicine.

Keyphrases

type diabetes
end stage renal disease
glycemic control
ejection fraction
chronic kidney disease
newly diagnosed
cardiovascular disease
peritoneal dialysis
prognostic factors
insulin resistance
patient reported outcomes
stem cells
skeletal muscle